February, 9, 2024: @ Cité Internationale Universitaire de Paris
08:30 - 09:15 Welcome & Coffee
09:15 - 09:20 Welcome remarks by PASREL-Imagerie
09:20 - 09:45 Opening
09:45 - 10:30 Conference - Development of photoacoustic imaging to assess delivery and therapeutic efficacy
Lori BRIDAL – Director of Biomedical Imaging Laboratory
Jérôme GATEAU - Research associate at Biomedical Imaging Laboratory
10:30 - 11:00 Biotech Pitch
Delphine FELDER-FLESCH - CEO: "SUPERBRANCHE, a nanotechnology for MRI, MPI and ultrasound imaging"
Romain LEGRAND – CEO: "RonomA, an innovative approach for Alzheimer's disease"
Florent PERIN-DUREAU – Co-founder and CMO: Rest Therapeutics
Benoît LARRAT – Co-founder & CEO : TheraSonic
11:00 - 11:30 Coffee break & Networking
11:30 - 12:15 Round table - Links between academic and industrial players in the drug value chain
Olivier BARRET - Head of PET Laboratory - CEA / MIRCen (Molecular Imaging Research Center
Lori BRIDAL – Director of Biomedical Imaging Laboratory
Eftychia KOUMARIANOU – Head of Pharmacoimaging and Molecular Radiotherapy Department - Oncodesign Services
Benoit LABARTHE - Head of research and Technology Transfer - French Agency for Health Innovation
Etienne LONCHAMP – Innovation project Manager - Diagnostic sector - Medicen
Franck MOUTHON – President - France Biotech
12:15 - 14:00 Lunch & Networking
14:00 - 14:45 Conference - MRI to support drug development : opportunities and challenges
Bernard GALLEZ - Biomedical Magnetic Resonance Research Group / Louvain Drug Research Institute (LDRI) - UCLouvain
14:45 - 15:15 Successful academic/industrial collaborations for drug development using imaging
Jean-Luc GENNISSON - Head of "Methodological and instrumental developments" - BioMaps Laboratory
Adrien BESSON - Lead Ultrasound - e-Scopics
Contribution of ultra-high-field MRI iron imaging to research for neurodegenerative diseases and their therapeutics
Alexandre VIGNAUD - Head of METRIC laboratory - NeuroSpin / CEA
Stéphane ROCHE - CTO - Ventio
